Table 1.
Baseline characteristics of patients with Covid-19 included in the study
| No. (%) | |
|---|---|
| Demographic information | |
| Total No. | 531 |
| Age, median (IQR), year | 59 (50–69) |
| Gender | |
| Female | 171 (32.2%) |
| Male | 360 (67.8%) |
| Ethnicity | |
| Caucasian | 449 (84.6%) |
| Latin American | 70 (13.2%) |
| Asian | 8 (1.5%) |
| Sub-Saharan African | 4 (0.8%) |
| BMI, median (IQR), kg/m2 | 27 (24–30) |
| Comorbidities | |
| Total No. | 531 |
| Hypertension | 177 (33.3%) |
| Coronary artery disease | 34 (6.4%) |
| Diabetes | |
| Type 1 | 5 (0.9%) |
| Type 2 | 68 (12.8% |
| Cancera | 11 (2.1%) |
| Chronic obstructive pulmonary disease | 10 (1.8%) |
| Neurological disabilities | 11 (2.1%) |
| Laboratory results at admission | |
| pH, median (IQR) | 7.47 (7.44–7.5) |
| Ionized calcium levels, median (IQR), mmol/L | |
| Actual calcium | 1.1 (1.07–1.15) |
| Standardized calcium | 1.14 (1.1–1.17) |
| eGFR, median (IQR), mL/min/1.73 m2 | 85 (68.8–97.7) |
| Total calcium levelsb, median (IQR), mmol/L | 2.14 (2.05–2.2) |
| LDH, median (IQR), U/L | 359 (273–457) |
| CRP, median (IQR), mg/L | 66 (26.2–123.4) |
BMI body mass index; COVID-19 coronavirus disease 2019, IQR interquartile range
aOnly active neoplasms were included in this section
bCalcium values at admission have not been corrected for serum albumin